MTMicaela Tjäderborn

Micaela Tjäderborn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Micaela Tjäderborn has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Johan Ahlner

    Division of Drug Research/Clinical Pharmacology, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden; Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden

    2 shared publications
  • Staffan Hägg

    Department of Drug Research/Clinical Pharmacology, Linköping University, Linköping, Sweden

    2 shared publications
  • Anna K Jönsson

    Nordic School of Public Health, Gothenburg, Sweden

    1 shared publication
  • Anna K. Jönsson

    Division of Drug Research/Clinical Pharmacology, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden; Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden

    1 shared publication
  • Anna K. Jönsson

    Nordic School of Public Health, Gothenburg, Sweden

    1 shared publication
  • Henrik Druid

    Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

    1 shared publication

Latest Publications

  • Non-prescribed use of psychoactive prescription drugs among drug-impaired drivers in Sweden

    by Micaela Tjäderborn, Anna K. Jönsson, Tatiana Zverkova Sandström, Johan Ahlner, Staffan Hägg


  • Tramadol dependence: a survey of spontaneously reported cases in Sweden

    by Micaela Tjäderborn, Anna K Jönsson, Johan Ahlner, Staffan Hägg

    Background: Tramadol is a weak opioid analgesic, which is generally considered to be safe. However, conflicting data exist on the dependence potential of tramadol.Objective: The aim of this study was to investigate occurrence of tramadol dependence and associated risk factors using spontaneously reported adverse drug reactions.Methods: The Swedish database for spontaneously reported adverse drug reactions, Swedish Drug Information System (SweDIS), was searched for reports on tramadol dependence from 1 January 1995 until 31 December 2006. Selection was conducted based on the DSM‐IV definition of dependence. Available information was scrutinised and registered and then presented descriptively.Results: A total of 104 reports of tramadol dependence were identified, of which 60 (58%) concerned women. The median age (range) was 45 (15–84) years. Information on a history of substance abuse was present in 31 patients (30%) and 41 patients (39%) had a documented past or current use of a drug of abuse. Prescribed doses of tramadol ranged between 50–800 mg/day, and ingested doses between 50–4000 mg/day. Time of onset ranged from some weeks up to 4 years. In 72 (69%) cases the reaction was classified as serious, mainly due to hospitalisations for detoxification or discontinuation of tramadol.Conclusions: There is an occurrence of tramadol dependence in association with analgesic treatment within the recommended dose range. In susceptible patients a severe and serious dependence syndrome may develop. A history of abuse or use of a drug of abuse seems to be an important risk factor. Copyright © 2009 John Wiley & Sons, Ltd.


  • Open Access

    Fatal drug poisonings in a Swedish general population

    by Anna K Jönsson, Olav Spigset, Micaela Tjäderborn, Henrik Druid, Staffan Hägg

    Pharmaceutical drug poisonings have previously been reported using single sources of information, either hospital data or forensic data, which might not reveal the true incidence. We therefore aimed to estimate the incidence of suspected fatal drug poisonings, defined as poisonings by pharmaceutical agents, by using all relevant case records from various sources in a Swedish population.